Has success spoiled hairy cell leukemia research? Key questions go unanswered, despite big gains.
Holzman
David
D
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000266:history / Q000494:pharmacology* / Q000627:therapeutic use; D035843:Biomedical Research / Q000266:history / Q000639:trends*; D001853:Bone Marrow / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D017338:Cladribine / Q000494:pharmacology; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007372:Interferons / Q000494:pharmacology; D007943:Leukemia, Hairy Cell / Q000188:drug therapy / Q000266:history / Q000276:immunology / Q000401:mortality / Q000473:pathology; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects*; D009705:Nucleosides / Q000009:adverse effects* / Q000494:pharmacology*; D015649:Pentostatin / Q000494:pharmacology; D000069283:Rituximab; D000078329:Workforce
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009705:Nucleosides; D015649:Pentostatin; D017338:Cladribine; D000069283:Rituximab; D007372:Interferons